Probiotics Alleviate the Progressive Deterioration of Motor Functions in a Mouse Model of Parkinson’s Disease
Open accessThe DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) is one of the common long-term degenerative disorders that primarily affect motor systems. Gastrointestinal (GI) symptoms are common in individuals with PD and often present before motor symptoms. It has been found that gut dysbiosis to PD pathology is related to the severity of motor and non-motor symptoms in PD. Probiotics have been reported to have the ability to improve the symptoms related to constipation in PD patients. However, the evidence from preclinical or clinical research to verify the beneficial effects of probiotics for the motor functions in PD is still limited. An experimental PD animal model could be helpful in exploring the potential therapeutic strategy using probiotics. In the current study, we examined whether daily and long-term administration of probiotics has neuroprotective effects on nigrostriatal dopamine neurons and whether it can further alleviate the motor dysfunctions in PD mice. Transgenic MitoPark PD mice were chosen for this study and the effects of daily probiotic treatment on gait, beam balance, motor coordination, and the degeneration levels of dopaminergic neurons were identified. From the results, compared with the sham treatment group, we found that the daily administration of probiotics significantly reduced the motor impairments in gait pattern, balance function, and motor coordination. Immunohistochemically, a tyrosine hydroxylase (TH)-positive cell in the substantia nigra was significantly preserved in the probiotic-treated PD mice. These results showed that long-term administration of probiotics has neuroprotective effects on dopamine neurons and further attenuates the deterioration of motor dysfunctions in MitoPark PD mice. Our data further highlighted the promising possibility of the potential use of probiotics, which could be the relevant approach for further application on human PD subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, positive effects of probiotic strains in in vitro and in vivo models of Parkinson's disease were reported by Castelli et al. [441] and Hsieh et al. [442].”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [442]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Tamtaji, O. R., Taghizadeh, M., Daneshvar Kakhaki, R., Kouchaki, E., Bahmani, F., Borzabadi, S., Oryan, S., Mafi, A., & Asemi, Z. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.05.018 · Cited by 398 · cited 3×
“Probiotics have been demonstrated as having potential for PD, including the improvement of stool consistency and bowel habits and the reduction of scores from the Movement Disorders Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) [28,29].”
MethodResultRetractedGastrointestinal dysfunction in idiopathic Parkinsonism: A narrative review
Salari, M., Fayyazi, E., & Mirmosayyeb, O. (2016) · Journal of Research in Medical Sciences · doi:10.4103/1735-1995.196608 · Cited by 4
RetractedRole of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385 · cited 1×
“In addition to the use of peptides for the improvement of gastrointestinal or digestive dysfunctions [13,20–22], and in order to improve GI function and the balance of microbiota, probiotics could be one of the powerful tools to be used for altering the PD-associated microbiota composition and mitigating the related i…”
BackgroundGut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968 · cited 1×
“The lower levels of Lachnospiraceae and higher levels of Enterobacteriaceae families have been correlated with the severity of the disease, postural instability, gait difficulty, and motor impairment (assessed by MDS-UPDRS III and Hoehn and Yahr stage) [51,53].”
MethodNeurotransmitter modulation by the gut microbiota
Strandwitz, P. (2018) · Brain Research · doi:10.1016/j.brainres.2018.03.015 · Cited by 1,527 · cited 1×
“Animal studies show that microbiota-based interventions can influence host physiology by modulating the function of mammalian neurotransmitters, such as dopamine, norepinephrine, and serotonin [60].”
BackgroundMicrobiota and neurodevelopmental windows: implications for brain disorders
Borre, Y. E., O’Keeffe, G. W., Clarke, G., Stanton, C., Dinan, T. G., & Cryan, J. F. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.05.002 · Cited by 1,089
Forsyth, C. B., Shannon, K. M., Kordower, J. H., Voigt, R. M., Shaikh, M., Jaglin, J. A., Estes, J. D., Dodiya, H. B., & Keshavarzian, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028032 · Cited by 974
Hill‐Burns, E. M., Debelius, J. W., Morton, J. T., Wissemann, W. T., Lewis, M. R., Wallen, Z. D., Peddada, S. D., Factor, S. A., Molho, E., Zabetian, C. P., et al. (2017) · Movement Disorders · doi:10.1002/mds.26942 · Cited by 874
Sun, M.-F., Zhu, Y.-L., Zhou, Z.-L., Jia, X.-B., Xu, Y.-D., Yang, Q., Cui, C., & Shen, Y.-Q. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.02.005 · Cited by 736 · cited 3×
“Earlier studies have reported that the administration of probiotics increased the levels of BDNF and GDNF, which are required for the survival of dopaminergic neurons in vivo [67,69].”
BackgroundTime-course gait analysis of hemiparkinsonian rats following 6-hydroxydopamine lesion
Hsieh, T.-H., Chen, J.-J. J., Chen, L.-H., Chiang, P.-T., & Lee, H.-Y. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.03.031 · Cited by 684
Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons
Ekstrand, M. I., Terzioglu, M., Galter, D., Zhu, S., Hofstetter, C., Lindqvist, E., Thams, S., Bergstrand, A., Hansson, F. S., Trifunovic, A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605208103 · Cited by 605 · cited 5×
“The MitoPark PD mouse can exhibit the cardinal features of PD, such as the adult onset of degeneration in dopaminergic neurons and the progressive deterioration in motor functions [31,32].”
BackgroundInfluentialBrain-Gut-Microbiota Axis in Parkinson’s Disease
Mulak, A. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i37.10609 · Cited by 583
The blood-brain barrier and immune function and dysfunction
Banks, W. A., & Erickson, M. A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.031 · Cited by 523 · cited 1×
“Furthermore, the higher levels of gut-derived LPSs could promote the neuroinflammation and damage in substantial nigra via the disruption of blood–brain barrier (BBB) integrity [70].”
BackgroundShort-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats
Fukumoto, S., Tatewaki, M., Yamada, T., Fujimiya, M., Mantyh, C., Voss, M., Eubanks, S., Harris, M., Pappas, T. N., & Takahashi, T. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00442.2002 · Cited by 465
Serotonin: A Mediator of The Brain–Gut Connection
Kim, D.-Y., & Camilleri, M. (2000) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03177.x · Cited by 448
Probiotics and prebiotic fiber for constipation associated with Parkinson disease: An RCT
Barichella, M., Pacchetti, C., Bolliri, C., Cassani, E., Iorio, L., Pusani, C., Pinelli, G., Privitera, G., Cesari, I., Faierman, S. A., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003127 · Cited by 390 · cited 1×
“Other human studies have also shown several beneficial effects of probiotics in PD, including the alleviation of the symptoms in abdominal pain, bloating, and constipation and the improvements in stool consistency and defecation habits [28,48,49].”
BackgroundProbiotics, prebiotics and amelioration of diseases
Tsai, Y.-L., Lin, T.-L., Chang, C.-J., Wu, T.-R., Lai, W.-F., Lu, C.-C., & Lai, H.-C. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-018-0493-6 · Cited by 388
Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson’s Disease
Caputi, V., & Giron, M. C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061689 · Cited by 338 · cited 1×
“It has been found that PD patients have greater intestinal permeability (gut leakiness), which might upregulate the local/systemic inflammatory response and oxidative stress induced by lipopolysaccharides (LPSs, also termed endotoxin), leading to α-synucleinopathy in the enteric nervous system [13].”
BackgroundSerotonin in Parkinson's disease
Politis, M., & Niccolini, F. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.037 · Cited by 306 · cited 1×
“Similar to the dopaminergic denervation in PD, the loss of serotoninergic terminals was also found in PD [64].”
Non-conventional features of peripheral serotonin signalling — the gut and beyond
Spohn, S. N., & Mawe, G. M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.51 · Cited by 282
Gut-Brain Psychology: Rethinking Psychology From the Microbiota–Gut–Brain Axis
Liang, S., Wu, X., & Jin, F. (2018) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2018.00033 · Cited by 263
Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study
Minato, T., Maeda, T., Fujisawa, Y., Tsuji, H., Nomoto, K., Ohno, K., & Hirayama, M. (2017) · PLOS ONE · doi:10.1371/journal.pone.0187307 · Cited by 248 · cited 1×
“Furthermore, the abundance of Lachnospiraceae and Enterobacteriaceae are related to disease severity, disease progression, and motor impairment in PD [53,54].”
BackgroundBacterial Translocation from the Gut to the Distant Organs: An Overview
Nagpal, R., & Yadav, H. (2017) · Annals of Nutrition and Metabolism · doi:10.1159/000479918 · Cited by 234
Gut microbiota: Implications in Parkinson's disease
Parashar, A., & Udayabanu, M. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.02.002 · Cited by 230
Dysbiosis of gut microbiota in a selected population of Parkinson's patients
Pietrucci, D., Cerroni, R., Unida, V., Farcomeni, A., Pierantozzi, M., Mercuri, N. B., Biocca, S., Stefani, A., & Desideri, A. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.06.003 · Cited by 217 · cited 2×
“Furthermore, the abundance of Lachnospiraceae and Enterobacteriaceae are related to disease severity, disease progression, and motor impairment in PD [53,54].”
BackgroundMethodSrivastav, S., Neupane, S., Bhurtel, S., Katila, N., Maharjan, S., Choi, H., Hong, J. T., & Choi, D.-Y. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.03.021 · Cited by 212 · cited 3×
“Earlier studies have reported that the administration of probiotics increased the levels of BDNF and GDNF, which are required for the survival of dopaminergic neurons in vivo [67,69].”
BackgroundMind-altering with the gut: Modulation of the gut-brain axis with probiotics
Kim, N., Yun, M., Oh, Y. J., & Choi, H.-J. (2018) · Journal of Microbiology · doi:10.1007/s12275-018-8032-4 · Cited by 210 · cited 2×
“ize starch, maltodextrins, and vegetable protein [27,33,34].”
Background(2011) · PubMed · Cited by 207
Prepharyngeal dysphagia in Parkinson's disease
Leopold, N. A., & Kagel, M. C. (1996) · Dysphagia · doi:10.1007/bf00385794 · Cited by 192
Rodes, L. (2013) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1205.05018 · Cited by 173 · cited 1×
“casei LABPC) may decrease colonic LPS concentrations and reduce the proinflammatory tone and decrease the LPS-induced neuroinflammation in in vitro and in vivo studies [71,72].”
BackgroundDo your gut microbes affect your brain dopamine?
González‐Arancibia, C., Urrutia-Piñones, J., Illanes-González, J., Martínez-Pinto, J., Sotomayor‐Zárate, R., Julio‐Pieper, M., & Bravo, J. A. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05265-5 · Cited by 164 · cited 1×
“Interestingly, manipulation of the microbiota can affect intestinal mobility by modulating dopamine or serotonin in the gut, as well as the turnover rate of dopamine and serotonin in the brain [65].”
BackgroundErickson, J. T., Brosenitsch, T. A., & Katz, D. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00581.2001 · Cited by 163 · cited 1×
“Earlier studies have reported that the administration of probiotics increased the levels of BDNF and GDNF, which are required for the survival of dopaminergic neurons in vivo [67,69].”
BackgroundCersosimo, M. G., & Benarroch, E. E. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.09.030 · Cited by 163
Li, H., Wang, P., Huang, L., Li, P., & Zhang, D. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13677 · Cited by 160 · cited 1×
“In an earlier animal study, it was found that probiotics have an effect on regulating the intestinal flora composition and the metabolism of serotonin [66].”
BackgroundEkstrand, M. I., & Galter, D. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70811-9 · Cited by 155 · cited 1×
“, abnormal locomotor function, tremor, and twitching) at 14–20 weeks of age in the MitoPark mice [31,40,47].”
BackgroundProbiotics for Parkinson’s Disease
Gazerani, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174121 · Cited by 151 · cited 1×
“However, there is insufficient preclinical or clinical evidence to show the beneficial effects of probiotics in PD, and detailed underlying effects and mechanisms of probiotics in PD still need further clarification [30].”
BackgroundProbiotics may have beneficial effects in parkinson’s disease: In vitro evidence
Magistrelli, L., Amoruso, A., Mogna, L., Graziano, T., Cantello, R., Pane, M., & Comi, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00969 · Cited by 144
The Gut and Parkinson's Disease—A Bidirectional Pathway
Santos, S. F., de Oliveira, H. L., Yamada, E. S., Neves, B. C., & Pereira, A. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00574 · Cited by 140
Nonmotor gastrointestinal disorders in older patients with Parkinson’s disease: is there hope?
Georgescu, D., Ancusa, O., Georgescu, L., Ionita, I., & Reisz, D. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s106284 · Cited by 138
Gut Microbiota and Endothelial Dysfunction Markers in Obese Mexican Children and Adolescents
Nirmalkar, K., Murugesan, S., Pizano-Zárate, M. L., Villalobos-Flores, L. E., García-González, C., Morales‐Hernández, R. M., Núñez-Hernández, J. A., Hernández-Quiroz, F., Romero‐Figueroa, M. D. S., Hernández‐Guerrero, C., et al. (2018) · Nutrients · doi:10.3390/nu10122009 · Cited by 132
Brain-gut axis in pancreatic secretion and appetite control.
Konturek, S. J., Pepera, J., Zabielski, K., Konturek, P. C., Pawlik, T., Szlachcic, A., & Hahn, E. G. (2003) · PubMed · Cited by 130
Gastrointestinal Dysfunctions in Parkinson’s Disease: Symptoms and Treatments
Poirier, A.-A., Aubé, B., Côté, M., Morin, N., Di Paolo, T., & Soulet, D. (2016) · Parkinson s Disease · doi:10.1155/2016/6762528 · Cited by 130
Rial, D., Castro, A. A., Machado, N., Garção, P., Gonçalves, F. Q., Silva, H. B., Tomé, Â. R., Köfalvi, A., Corti, O., Raisman-Vozari, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114216 · Cited by 122 · cited 3×
“Pathologically, PD is characterized by progressive degeneration of dopaminergic cells in the substantia nigra pars compacta (SNpc), leading to extrapyramidal motor dysfunctions, such as gait disturbance, resting tremor, rigidity, bradykinesia, and postural instability [2].”
BackgroundMethodOnyszchuk, G., He, Y.-Y., Berman, N. E. J., & Brooks, W. M. (2008) · Journal of Neurotrauma · doi:10.1089/neu.2007.0430 · Cited by 120 · cited 1×
“A rotarod test is a suitable tool for evaluating motor coordination and balance function [2,39,40].”
Parkinson’s disease: experimental models and reality
Jiang, P., & Dickson, D. W. (2018) · Acta Neuropathologica · doi:10.1007/s00401-017-1788-5 · Cited by 111 · cited 1×
“Parkinson’s disease (PD) is one of the common age-related and progressive movement disorders [1,2].”
BackgroundMusa, N. H., Mani, V., Lim, S. M., Vidyadaran, S., Abdul Majeed, A. B., & Ramasamy, K. (2017) · Journal of Dairy Research · doi:10.1017/s0022029917000620 · Cited by 100 · cited 1×
“casei LABPC) may decrease colonic LPS concentrations and reduce the proinflammatory tone and decrease the LPS-induced neuroinflammation in in vitro and in vivo studies [71,72].”
BackgroundMatter, A. M., Folweiler, K. A., Curatolo, L. M., & Kline, A. E. (2011) · Neurorehabilitation and neural repair · doi:10.1177/1545968310397206 · Cited by 72 · cited 2×
“was videotaped and then the average duration of the elapsed time to traverse the beam within five trials was calculated [37,38].”
MethodJones, J. D., Rahmani, E., Garcia, E., & Jacobs, J. P. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.01.009 · Cited by 70
Li, X., Redus, L., Chen, C., Martinez, P. A., Strong, R., Li, S., & O’Connor, J. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071341 · Cited by 66 · cited 2×
“The MitoPark PD mouse can exhibit the cardinal features of PD, such as the adult onset of degeneration in dopaminergic neurons and the progressive deterioration in motor functions [31,32].”
BackgroundCan the gut be the missing piece in uncovering PD pathogenesis?
Chapelet, G., Leclair-Visonneau, L., Clairembault, T., Neunlist, M., & Derkinderen, P. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.11.014 · Cited by 59
The Role of Gut–brain Axis in Regulating Glucose Metabolism After Acute Pancreatitis
Pendharkar, S. A., Asrani, V. M., Murphy, R., Cutfield, R. G., Windsor, J. A., & Petrov, M. S. (2017) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2016.63 · Cited by 56
Hsieh, T.-H., Kang, J.-W., Lai, J.-H., Huang, Y., Rotenberg, A., Chen, K., Wang, J., Chan, S., Chen, S.-C., Chiang, Y. H., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178186 · Cited by 50 · cited 4×
“All mice were trained to walk or run from a bright light point toward the dark home cage by traversing a beam at least four times bef re formal recording [36,37].”
BackgroundMethodMicrobial treatment: the potential application for Parkinson’s disease
Fang, X. (2018) · Neurological Sciences · doi:10.1007/s10072-018-3641-6 · Cited by 49 · cited 5×
“Earlier studies have reported that the administration of probiotics increased the levels of BDNF and GDNF, which are required for the survival of dopaminergic neurons in vivo [67,69].”
BackgroundInfluentialGhaisas, S., Langley, M. R., Palanisamy, B. N., Dutta, S., Narayanaswamy, K., Plummer, P. J., Sarkar, S., Ay, M., Jin, H., Anantharam, V., et al. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.09.004 · Cited by 49 · cited 1×
“It has been reported the MitoPark mice can exhibit the cardinal features of PD, such as the adult onset of neurodegeneration, progressive deterioration of motor functions, GI dysfunctions, and gut microbiome cha ges [31,32,46].”
BackgroundA nutritional approach to microbiota in Parkinson’s disease
UYAR, G. Ö., & YILDIRAN, H. (2019) · Bioscience of Microbiota, Food and Health · doi:10.12938/bmfh.19-002 · Cited by 44 · cited 1×
“In addition to the use of peptides for the improvement of gastrointestinal or digestive dysfunctions [13,20–22], and in order to improve GI function and the balance of microbiota, probiotics could be one of the powerful tools to be used for altering the PD-associated microbiota composition and mitigating the related i…”
BackgroundDembiński, A., Warzecha, Z., Ceranowicz, P., Dembiński, M., Cieszkowski, J., Gosiewski, T., Bulanda, M., Kuśnierz-Cabala, B., Gałązka, K., & Konturek, P. C. (2016) · Gastroenterology Research and Practice · doi:10.1155/2016/3126280 · Cited by 38
Liang, J. I., Lin, P. C., Chen, M.-Y., Hsieh, T.-H., Chen, J. J., & Yeh, M. L. (2013) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-013-5036-9 · Cited by 35
Warzecha, Z., DEMBINSKI, A. B., Ceranowicz, P., Stachura, J., Tomaszewska, R., & Konturek, S. J. (2001) · PubMed · Cited by 34
DEMBINSKI, A. B., Warzecha, Z., KONTUREK, P., Ceranowicz, P., & Konturek, S. J. (1996) · International Journal of Pancreatology · doi:10.1007/bf02787366 · Cited by 32
Woitalla, D., Kassubek, J., Timmermann, L., Lauterbach, T., Berkels, R., Grieger, F., & Müller, T. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.11.024 · Cited by 32
Quantitative video-based gait pattern analysis for hemiparkinsonian rats
Lee, H.-Y., Hsieh, T.-H., Liang, J.-I., Yeh, M., & Chen, J.-J. J. (2012) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-012-0933-5 · Cited by 30 · cited 1×
“The procedures of gait analysis to measure the gait disturbance in PD mice were described previously [42,43].”
MethodLai, J.-H., Chen, K., Wu, J. C.-C., Olson, L., Brené, S., Huang, C.-Z., Chen, Y., Kang, S.-J., Ma, K., Hoffer, B. J., et al. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146301 · Cited by 28 · cited 2×
“, abnormal locomotor function, tremor, and twitching) at 14–20 weeks of age in the MitoPark mice [31,40,47].”
BackgroundMethodRole of sensory nerves in pancreatic secretion and caerulein-induced pancreatitis.
Warzecha, Z., DEMBINSKI, A. B., Jaworek, J. M., Ceranowicz, P., Szlachcic, A., Walocha, J., & Konturek, S. J. (1997) · PubMed · Cited by 27
O’Brien, R., & O’Malley, D. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13738 · Cited by 24
DEMBINSKI, A. B., Warzecha, Z., Ceranowicz, P., Jaworek, J. M., Sendur, R., Knafel, A., Dembiński, M., Bilski, J., Pawlik, W. W., Tomaszewska, R., et al. (2003) · PubMed · Cited by 22
DEMBINSKI, A. B., Warzecha, Z., Ceranowicz, P., & Konturek, S. J. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)27201-1 · Cited by 20
Liu, N., Zhang, Y.-P., Zou, J., Verhovshek, T., Chen, C., Lu, Q., Walker, C. L., Shields, C. B., & Xu, X. (2014) · Brain Research · doi:10.1016/j.brainres.2014.05.042 · Cited by 20 · cited 1×
“Five trials were measured in each mouse with a 15 min interval between trials [41].”
MethodHameed, M. Q., Goodrich, G. S., Dhamne, S. C., Amandusson, Å., Hsieh, T.-H., Mou, D., Wang, Y., & Rotenberg, A. (2014) · Neuroreport · doi:10.1097/wnr.0000000000000132 · Cited by 19 · cited 2×
“All mice were trained to walk or run from a bright light point toward the dark home cage by traversing a beam at least four times bef re formal recording [36,37].”
BackgroundTsai, W.-L., Chen, H., Huang, Y., Chen, Y.-H., Kuo, C.-W., Chen, K., & Hsieh, T.-H. (2019) · Behavioural Neurology · doi:10.1155/2019/4829572 · Cited by 19 · cited 1×
“Finally, the sections were further dehydrated using xylol (Sinopharm, Shanghai, China) and cleared in xylene and cover-slipped in DPX [45].”
MethodHsieh, T.-H., Kang, J.-W., Lai, J.-H., Huang, Y., Rotenberg, A., Chen, K., Wang, J., Chan, S., Chen, S.-C., Chiang, Y. H., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182300 · Cited by 9
Jaworek, J. M., Tudek, B., Kowalczyk, P., Kot, M., Szklarczyk, J., Leja‐Szpak, A., Pierzchalski, P., Bonior, J., DEMBINSKI, A. B., Ceranowicz, P., et al. (2018) · Gastroenterology Research and Practice · doi:10.1155/2018/6915059 · Cited by 9
Exponential function for calculating saturable enzyme kinetics.
Keller, F., Emde, C., & Schwarz, A. (1988) · Clinical Chemistry · doi:10.1093/clinchem/34.12.2486 · Cited by 9 · cited 1×
“A traditional lamp (with a 60-watt incandescent bulb) was applied to provid an aversive sti ulus at the starting point [35].”
MethodDEMBINSKI, A. B., Warzecha, Z., Ceranowicz, P., Pawlik, M., Dembiński, M., Kabat, K., Konturek, S. J., Kownacki, P., Hładki, W., & Ww, P. (2004) · PubMed · Cited by 6
Cited by
The gut microbiota–brain axis in behaviour and brain disorders
Morais, L. H., Schreiber, H. L., & Mazmanian, S. K. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00460-0 · Cited by 2,149
The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders
Socała, K., Doboszewska, U., Szopa, A., Serefko, A., Włodarczyk, M., Zielińska, A., Poleszak, E., Fichna, J., & Wlaź, P. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105840 · Cited by 857
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders
Sorboni, S. G., Moghaddam, H. S., Jafarzadeh-Esfehani, R., & Soleimanpour, S. (2022) · Clinical Microbiology Reviews · doi:10.1128/cmr.00338-20 · Cited by 522
Probiotics, prebiotics and amelioration of diseases
Tsai, Y.-L., Lin, T.-L., Chang, C.-J., Wu, T.-R., Lai, W.-F., Lu, C.-C., & Lai, H.-C. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-018-0493-6 · Cited by 388
Microbiota and the gut-brain-axis: Implications for new therapeutic design in the CNS
Liu, L., Huh, J. R., & Shah, K. (2022) · eBioMedicine · doi:10.1016/j.ebiom.2022.103908 · Cited by 344
Metadata
- Authors
- Hsieh, T.-H., Kuo, C.-W., Hsieh, K.-H., Shieh, M.-J., Peng, C.-W., Chen, Y.-C., Chang, Y.-L., Huang, Y.-Z., Chen, C.-C., Chang, P.-K., Chen, K.-Y., & Chen, H.-Y.
- Affiliations
- Chang Gung University (TW)
- National Taiwan University (TW)
- Tajen University (TW)
- Taipei Medical University (TW)
- Taichung Veterans General Hospital (TW)
- Corresponding author
- Chen, Hsin-Yung
- ORCID
- Venue
- Brain Sciences
- Publisher
- MDPI AG
- Published
- 2020-04-01
- Volume
- 10
- Issue
- 4
- Pages
- 206
- ISSN
- 2076-3425 (ISSN-L)
- PMC
- PMC7226147
- OpenAlex
- W3014346200
- Cited by
- 174
- References
- 73
- Citations by year
- 2026: 17 · 2025: 27 · 2024: 29 · 2023: 35 · 2022: 33 · 2021: 22 · 2020: 9
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Brain Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministry of Science and Technology, Taiwan (106-2410-H-182-008-MY2, 108-2314-B-182-011)
- Chang Gung Memorial Hospital (CMRPD1H0461, CMRPD1H0462, CMRPD1F0501, CMRPD3H0021)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- probiotics, Parkinson's disease, motor impairment, neuroprotection, dopaminergic neurons, substantia nigra, gut dysbiosis, tyrosine hydroxylase, gait, balance, motor coordination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.